Pelthos Therapeutics Inc. PTHS Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $31.98M+24,250% | $17.97M+3,404% | $14.2M+1,032% | $59.17K-97.5% | $131.32K-96.5% | ||
| $11.7M— | $8.86M— | $7.99M— | —— | $0— | ||
| $23.42M— | $23.57M— | $24.1M— | —— | $0— | ||
| $69.8M+7,561% | $53.41M+3,801% | $49.76M+2,225% | $822.85K-68.4% | $911.18K-77.4% | ||
| $9.31M— | $9.59M— | $10.17M— | —— | —— | ||
| $24.68M— | $24.68M— | $30.63M— | —— | —— | ||
| $38.44M— | $39.47M— | $32.52M— | —— | —— | ||
| $145.38M+15,855% | $130.4M+9,425% | $126.43M+5,808% | $822.85K-68.4% | $911.18K-77.4% | ||
| $6.15M+136% | $2.99M+57.4% | $5.67M+343% | $4.99M+497% | $2.6M+8.1% | ||
| $978K— | $966K— | $1.52M— | —— | —— | ||
| $25M+390% | $25.99M+537% | $24.77M+594% | $7.32M+163% | $5.11M+76.0% | ||
| $26.36M— | $0— | —— | —— | —— | ||
| $110.28M+2,059% | $91.52M+2,141% | $68.18M+1,811% | $7.32M+163% | $5.11M+76.0% | ||
| 200M+32,206,019% | 200M— | 200M0.0% | 200M0.0% | 621-100.0% | ||
| -$75.03M-220% | -$64.79M-202% | -$43.13M-121% | -$26.89M-50.6% | -$23.44M-45.8% | ||
| $35.1M+937% | $38.88M+1,533% | $58.25M+4,179% | -$6.49M-3,429% | -$4.2M-471% | ||
| $145.38M+15,855% | $130.4M+9,425% | $126.43M+5,808% | $822.85K-68.4% | $911.18K-77.4% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Pelthos Therapeutics Inc.'s total assets?
- Pelthos Therapeutics Inc. (PTHS) holds $145.4M in total assets, up 15854.9% year over year.
- How much debt does Pelthos Therapeutics Inc. have?
- Pelthos Therapeutics Inc. carries $29.6M in total debt against $35.1M of shareholders' equity, a debt-to-equity ratio of 0.84.
- How much cash does Pelthos Therapeutics Inc. have?
- Pelthos Therapeutics Inc. holds $32.0M in cash and equivalents.
- Can Pelthos Therapeutics Inc. cover its short-term obligations?
- Its current ratio is 2.79 — current assets exceed current liabilities.
- Where does Pelthos Therapeutics Inc.'s balance sheet data come from?
- Every line is extracted from Pelthos Therapeutics Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
